Literature DB >> 23238129

Obesity with insulin resistance increase thrombosis in wild-type and bone marrow-transplanted Zucker Fatty rats.

Rodrigo Hernández Vera1, Gemma Vilahur, Lina Badimon.   

Abstract

Obesity induces metabolic and inflammatory alterations that contribute to the presentation of cardiovascular events. Although obesity is a risk factor for atherosclerosis and vascular disease, its role on thrombosis has not been directly explored. Therefore, we aimed to investigate the mechanisms by which obesity affects thrombosis. Thrombus formation was monitored by real-time intravital microscopy in Zucker Fatty rats (ZF) and lean controls (ZC). Crossed bone marrow (BM) transplants between ZF and ZC were performed. Intravital microscopy showed that ZF had significantly shorter occlusion times (OTs) than ZC, reflecting a three-fold higher thrombotic risk. Transplantation of ZC-BM to ZF recipients significantly reduced thrombosis, reducing their thrombotic risk to one third of that observed in non-transplanted ZF. Wild-type ZF showed increased platelet counts and increased platelet size compared to wild-type ZC and platelet number remained unaltered after transplantation. However, ZF-BM produced a significant increase in platelet size in ZC recipients. Thrombotic risk was found to be inversely correlated with both weight and insulin levels and directly correlated to HOMA-IR, while platelet number and size were directly correlated with weight. Thus, our data shows that obesity with insulin resistance significantly increases thrombosis and that alterations in BM-derived cells significantly contribute to this prothrombotic behaviour. Importantly, the reduction of insulin resistance was associated with reduced thrombotic risk even in the presence of obesity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238129     DOI: 10.1160/TH12-09-0696

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

Review 1.  The hematologic consequences of obesity.

Authors:  Johanna C Purdy; Joseph J Shatzel
Journal:  Eur J Haematol       Date:  2020-12-13       Impact factor: 2.997

2.  Allogenic adipose-derived stem cell therapy overcomes ischemia-induced microvessel rarefaction in the myocardium: systems biology study.

Authors:  Gemma Vilahur; Blanca Oñate; Judit Cubedo; Maria Teresa Béjar; Gemma Arderiu; Esther Peña; Laura Casaní; Manuel Gutiérrez; Antoni Capdevila; Guillem Pons-Lladó; Francesc Carreras; Alberto Hidalgo; Lina Badimon
Journal:  Stem Cell Res Ther       Date:  2017-03-09       Impact factor: 6.832

Review 3.  Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome.

Authors:  Eduardo Fuentes; Francisco Fuentes; Gemma Vilahur; Lina Badimon; Iván Palomo
Journal:  Mediators Inflamm       Date:  2013-06-13       Impact factor: 4.711

Review 4.  Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell-Derived Microvesicles to Repair the Ischemic Heart.

Authors:  Gemma Vilahur; Phuong Hue Nguyen; Lina Badimon
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-12       Impact factor: 3.947

5.  Analysis of platelets from a diet-induced obesity rat model: elucidating platelet dysfunction in obesity.

Authors:  María N Barrachina; Luis A Morán; Irene Izquierdo; Felipe F Casanueva; María Pardo; Ángel García
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379

6.  Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention.

Authors:  Jaqui Walker; Marco Cattaneo; Lina Badimon; Giancarlo Agnelli; Andrew T Chan; Angel Lanas; Bianca Rocca; Peter Rothwell; Paola Patrignani; Ruth Langley; Gemma Vilahur; Francesco Cosentino
Journal:  Ecancermedicalscience       Date:  2020-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.